Asensus Surgical Analyst Ratings
Asensus Surgical Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/22/2023 | 263.64% | Cantor Fitzgerald | → $1 | Reiterates | Overweight → Overweight |
08/11/2023 | 627.27% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
05/12/2023 | 627.27% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
03/06/2023 | 627.27% | HC Wainwright & Co. | $3 → $2 | Maintains | Buy |
02/22/2023 | 990.91% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
01/10/2023 | 990.91% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
09/08/2022 | 445.45% | Cantor Fitzgerald | → $1.5 | Initiates Coverage On | → Overweight |
08/10/2022 | 990.91% | HC Wainwright & Co. | $4 → $3 | Maintains | Buy |
05/26/2021 | 1354.55% | HC Wainwright & Co. | → $4 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
08/22/2023 | 263.64% | 坎託·菲茨傑拉德 | → 1 美元 | 重申 | 超重 → 超重 |
08/11/2023 | 627.27% | HC Wainwright & Co. | → 2 美元 | 重申 | 購買 → 購買 |
05/12/2023 | 627.27% | HC Wainwright & Co. | → 2 美元 | 重申 | 購買 → 購買 |
03/06/2023 | 627.27% | HC Wainwright & Co. | 3 美元 → 2 美元 | 維護 | 買 |
02/22/2023 | 990.91% | HC Wainwright & Co. | → 3 美元 | 重申 | → 購買 |
01/10/2023 | 990.91% | HC Wainwright & Co. | → 3 美元 | 重申 | → 購買 |
09/08/2022 | 445.45% | 坎託·菲茨傑拉德 | → 1.5 美元 | 啓動覆蓋範圍開啓 | → 超重 |
08/10/2022 | 990.91% | HC Wainwright & Co. | 4 美元 → 3 美元 | 維護 | 買 |
2021 年 5 月 26 日 | 1354.55% | HC Wainwright & Co. | → 4 美元 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Asensus Surgical (ASXC)?
Asensus Surgical (ASXC) 的目標價格是多少?
The latest price target for Asensus Surgical (AMEX: ASXC) was reported by Cantor Fitzgerald on August 22, 2023. The analyst firm set a price target for $1.00 expecting ASXC to rise to within 12 months (a possible 263.64% upside). 7 analyst firms have reported ratings in the last year.
坎託·菲茨傑拉德於2023年8月22日公佈了Asensus Surgical(美國證券交易所股票代碼:ASXC)的最新目標股價。該分析公司將目標股價定爲1.00美元,預計澳大利亞證券交易所將在12個月內升至12個月內(可能上漲263.64%)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Asensus Surgical (ASXC)?
分析師對Asensus Surgical(ASXC)的最新評級是多少?
The latest analyst rating for Asensus Surgical (AMEX: ASXC) was provided by Cantor Fitzgerald, and Asensus Surgical reiterated their overweight rating.
坎託·菲茨傑拉德對Asensus Surgical(美國證券交易所股票代碼:ASXC)的最新分析師評級由坎託·菲茨傑拉德提供,Asensus Surgical重申了其增持評級。
When is the next analyst rating going to be posted or updated for Asensus Surgical (ASXC)?
Asensus Surgical(ASXC)的下一個分析師評級何時公佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Asensus Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Asensus Surgical was filed on August 22, 2023 so you should expect the next rating to be made available sometime around August 22, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Asensus Surgical的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。Asensus Surgical的最新評級是在2023年8月22日發佈的,因此您應該預計下一個評級將在2024年8月22日左右公佈。
Is the Analyst Rating Asensus Surgical (ASXC) correct?
分析師對Asensus Surgical (ASXC) 的評級是否正確?
While ratings are subjective and will change, the latest Asensus Surgical (ASXC) rating was a reiterated with a price target of $0.00 to $1.00. The current price Asensus Surgical (ASXC) is trading at is $0.28, which is within the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但重申了最新的Asensus Surgical(ASXC)評級,目標股價爲0.00美元至1.00美元。Asensus Surgical(ASXC)目前的交易價格爲0.28美元,在分析師的預測區間內。
譯文內容由第三人軟體翻譯。